OncoGenex Announces Departure of CFO

Steve Anderson, chief financial officer (CFO), has agreed to leave OncoGenex Pharmaceuticals, a biopharmaceutical company.

OncoGenex has initiated an executive search to identify a CFO candidate suited for the next stage of company growth, with deep ties in the biopharma investment community and experience transitioning a pharmaceutical company from research and development (R&D) stage to commercial development.


Related reading